PHASE-II STUDY OF AZIRIDINYLBENZOQUINONE IN REFRACTORY LYMPHOMA

被引:0
作者
CASE, DC [1 ]
HAYES, DM [1 ]
机构
[1] MAINE MED CTR,DEPT MED,DIV ONCOL,PORTLAND,ME 04102
来源
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 11期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:993 / 996
页数:4
相关论文
共 19 条
  • [1] AISNER J, 1982, P AM SOC CLIN ONCOL, V1, P148
  • [2] ARONEY RS, 1982, P AN M AM SOC CLIN, V1, P24
  • [3] BEDIKIAN AY, 1982, AM J CLIN ONCOL-CANC, V5, P535
  • [4] CAREY RW, 1982, P AN M AM SOC CLIN, V1, P155
  • [5] CASE DC, 1976, CANCER TREAT REP, V60, P1217
  • [6] CASE DC, 1983, P ASCO, V2, P207
  • [7] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2.
    CHOU, F
    KHAN, AH
    DRISCOLL, JS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) : 1302 - 1308
  • [8] CURT GA, 1982, P AN M AM SOC CLIN, V1, P13
  • [9] ABILITY OF A NEW ANTI-TUMOR AGENT, AZQ, TO PENETRATE INTO CEREBROSPINAL-FLUID
    GORMLEY, PE
    WOOD, JH
    POPLACK, DG
    [J]. PHARMACOLOGY, 1981, 22 (03) : 196 - 198
  • [10] GRIFFIN JP, 1982, CANCER TREAT REP, V66, P1321